机译:贝伐单抗治疗HER2阴性转移性乳腺癌患者CEC计数的预后价值:预期验证研究(UCBG COMET)
1grid.440907.e0000 0004 1784 3645Department of Medical Oncology Institut CuriePSL Research;
1grid.440907.e0000 0004 1784 3645Department of Medical Oncology Institut CuriePSL Research;
3grid.418116.b0000 0001 0200 3174Department of Medical OncologyLeon Berard CenterLyonFrance;
15grid.440907.e0000 0004 1784 3645Department of Biostatistics Institut CuriePSL Research;
1grid.440907.e0000 0004 1784 3645Department of Medical Oncology Institut CuriePSL Research;
4Department of Medical OncologyGeorges-Fran?ois Leclerc CenterDijonFrance;
5grid.121334.60000 0001 2097 0141Department of Medical Oncology Institut du Cancer de Montpellier;
6grid.463833.90000 0004 0572 0656Aix-Marseille Univ Inserm U1068 CNRS UMR7258 Institut Paoli;
7grid.476460.70000 0004 0639 0505Department of Medical Oncology Institut BergonieBordeauxFrance;
8Department of Medical Oncology Fran?ois Baclesse CenterCaenFrance;
9Department of Medical Oncology Antoine Lacassagne CenterNiceFrance;
10grid.418448.50000 0001 0131 9695Department of Medical Oncology Institut Jean GodinotReimsFrance;
11Department of Medical OncologyICL Alexis VautrinVandoeuvre Les NancyFrance;
12Department of Medical Oncology Jean Perrin CenterClermont-FerrandFrance;
13grid.417829.10000 0000 9680 0846Department of Medical Oncology Institut Claudius Regaud IUCT;
14R&
D UNICANCER UCBGParisFrance;
15grid.440907.e0000 0004 1784 3645Department of Biostatistics Institut CuriePSL Research;
15grid.440907.e0000 0004 1784 3645Department of Biostatistics Institut CuriePSL Research;
1grid.440907.e0000 0004 1784 3645Department of Medical Oncology Institut CuriePSL Research;
1grid.440907.e0000 0004 1784 3645Department of Medical Oncology Institut CuriePSL Research;
Bevacizumab; Breast cancer; Circulating endothelial cells;
机译:贝伐单抗治疗HER2阴性转移性乳腺癌患者CEC计数的预后价值:预期验证研究(UCBG COMET)
机译:预后分数的前瞻性建设和验证,以鉴定患者在整体生存期间从第三线化疗中受益于转移性乳腺癌的患者:金属3研究
机译:预后分数的前瞻性建设和验证,以鉴定患者在整体生存期间从第三线化疗中受益于转移性乳腺癌的患者:金属3研究
机译:北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
机译:使用经过第一个周期血细胞计数训练的2期FOS-3NN模型预测正在接受化疗的乳腺癌患者的中性粒细胞减少。
机译:接受/不接受贝伐单抗化疗的晚期宫颈癌女性合并预后因素的前瞻性验证:NRG肿瘤学/ GOG研究
机译:接受/不接受贝伐单抗化疗的晚期宫颈癌女性合并预后因素的前瞻性验证:NRG肿瘤学/ GOG研究